E-LIB Suche - Ergebnisse für: Luraghi, Andrea

1

Istaroxime follow-on compounds: A new class of selective SE..:

Arici, Martina ; Hsu, Shih-Che ; Ferrandi, Mara...
Vascular Pharmacology. 155 (2024) - p. 107295 , 2024

Link: https://doi.org/10.1016/..

2

Selective SERCA2a activator as a candidate for chronic hear..:

Arici, Martina ; Hsu, Shih-Che ; Ferrandi, Mara...
Journal of Translational Medicine. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Selective SERCA2a activator as a candidate for chronic hear..:

Martina Arici ; Shih-Che Hsu ; Mara Ferrandi...
https://doi.org/10.1186/s12967-024-04874-9. , 2024

Link: https://doi.org/10.1186/..

4

MicroRNA 483‐3p overexpression unleashes invasive growth of..:

Candiello, Ermes ; Reato, Gigliola ; Verginelli, Federica...
Molecular Oncology. 17 (2023) 7 - p. 1280-1301 , 2023

Link: https://doi.org/10.1002/..

5

MicroRNA 483‐3p overexpression unleashes invasive growth of..:

Candiello, Ermes ; Reato, Gigliola ; Verginelli, Federica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323897/. , 2023

Link: http://www.ncbi.nlm.nih...

6

MicroRNA 483‐3p overexpression unleashes invasive growth of..:

Ermes Candiello ; Gigliola Reato ; Federica Verginelli...
https://doi.org/10.1002/1878-0261.13408. , 2023

Link: https://doi.org/10.1002/..

7

Temozolomide Treatment Alters Mismatch Repair and Boosts Mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
Cancer Discovery. 12 (2022) 7 - p. 1656-1675 , 2022

Link: https://doi.org/10.1158/..

8

Istaroxime metabolite PST3093 selectively stimulates SERCA2..:

Arici, Martina ; Ferrandi, Mara ; Hsu, Shih-Che...
Vascular Pharmacology. 146 (2022) - p. 107028 , 2022

Link: https://doi.org/10.1016/..

9

Highly Selective SERCA2a Activators: Preclinical Developmen..:

Luraghi, Andrea ; Ferrandi, Mara ; Barassi, Paolo...
Journal of Medicinal Chemistry. 65 (2022) 10 - p. 7324-7333 , 2022

Link: https://doi.org/10.1021/..

10

Temozolomide Treatment Alters Mismatch Repair and Boosts Mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394384/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Temozolomide treatment alters mismatch repair and boosts mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
info:eu-repo/semantics/altIdentifier/pmid/35522273. , 2022

Link: http://hdl.handle.net/23..

12

Highly Selective SERCA2a Activators: Preclinical Developmen..:

Luraghi, Andrea ; Ferrandi, Mara ; Barassi, Paolo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150102/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Temozolomide treatment alters mismatch repair and boosts mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
info:eu-repo/semantics/altIdentifier/pmid/35522273. , 2022

Link: http://hdl.handle.net/24..

14

Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mecha..:

Facchini, Fabio A. ; Minotti, Alberto ; Luraghi, Andrea...
Journal of Medicinal Chemistry. 64 (2021) 16 - p. 12261-12272 , 2021

Link: https://doi.org/10.1021/..

15

Ozonized Water Administration in Peri-Implant Mucositis Sit..:

Butera, Andrea ; Gallo, Simone ; Pascadopoli, Maurizio..
Applied Sciences. 11 (2021) 17 - p. 7812 , 2021

Link: https://doi.org/10.3390/..